AVITA Medical AVHHL Cash Flow Statement (2018-2026)

NASDAQ AVHHL
$2.00 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT
Reported Financials

AVITA Medical Quarterly Cash Flow Statement

Periods 31 quarters
Latest Jun 2026

AVITA Medical cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 31 quarters of results from Sep 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income
-10.71M-16.66M-9.46M-5.59M-4.17M-9.22M-10.38M-8.71M-8.96M-18.66M-15.39M-16.20M1.44M-13.86M-9.92M-13.19M-1.41M-7.66M
Share-based CompensationStock Comp.
2.74M4.58M1.76M2.93M1.77M2.13M2.50M2.64M2.68M2.68M2.17M3.54M4.03M4.08M2.80M4.52M5.15M5.15M1.37M5.09M
Gains from Investment SecuritiesGains Investment
0.72M0.87M-2.06M0.79M0.67M-0.38M-1.15M-0.04M-0.62M
Asset Writedowns and ImpairmentWritedown
0.02M
Cash from OperationsCash from Ops.
-12.54M-13.13M-9.37M6.84M-9.07M-9.10M-8.97M-10.86M-20.86M-12.78M-7.21M-8.04M-10.31M-10.23M-5.22M-5.44M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.34M0.52M0.16M-0.24M0.14M0.15M0.16M0.19M0.20M0.20M0.31M0.41M0.52M0.55M0.57M0.70M
Change in Working Capital
Change in ReceivablesChange Receivables
-1.54M-1.20M-0.36M1.11M-1.16M-1.28M-0.03M-1.70M0.50M-1.65M-1.51M-1.49M-0.25M1.63M2.34M-0.08M
Change in InventoryChange Inventory
-0.39M0.29M-0.23M0.46M0.75M0.25M1.40M1.29M1.66M-0.31M-0.31M1.12M1.44M-0.63M-0.14M-0.20M
Change in Accured ExpensesChange Accured Exp.
-0.98M-0.66M-2.45M3.91M-2.96M3.70M0.43M1.08M-2.17M0.77M3.21M0.68M2.33M-4.84M-2.15M7.40M
Other Working Capital ChangesOther WC Changes
0.48M0.42M-0.07M-0.56M-0.32M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M
Investing Activities
Capital ExpendituresCapex
0.74M0.76M0.30M-0.69M0.28M0.30M0.50M0.30M1.15M2.65M3.76M1.61M-0.26M1.00M0.93M-0.67M
Change in Acquisitions & DivestmentsChange Acquisitions
3.00M11.89M24.27M21.12M2.40M14.15M19.20M18.00M24.00M10.00M11.00M11.00M3.50M2.00M
Cash from Investing ActivitiesCash from Investing
-0.53M-50.18M-22.60M56.61M18.79M18.36M21.76M-57.30M15.07M12.43M7.39M2.47M10.77M7.02M-5.34M0.01M
Financing Activities
Other financing activitiesOther financing
0.07M-0.03M0.00M0.90M0.17M0.17M0.60M0.01M0.63M0.06M1.01M0.43M0.36M0.01M0.03M0.00M
Cash from Financing ActivitiesCash from Financing
64.06M-64.01M0.00M-64.06M0.17M0.17M0.60M39.43M0.63M0.85M1.01M1.02M0.36M0.56M13.77M0.25M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
0.44M0.19M0.02M0.04M0.74M0.04M0.97M1.16M1.94M1.21M2.01M
Net Equity Issued and RepurchasedNet Equity Issued
69.11M
Additional items
Exchange Rate EffectFX Effect
-0.01M-0.06M-0.01M0.04M0.00M0.00M-0.02M-0.00M
Change in Cash
50.98M-50.26M-31.98M-5.65M9.89M9.44M13.37M-28.74M-5.17M0.50M1.19M-4.59M0.82M-2.65M3.21M-5.18M
Free Cash FlowFCF
-13.27M-13.89M-9.68M7.53M-9.36M-9.40M-9.48M-11.16M-22.01M-15.43M-10.97M-9.65M-10.05M-11.23M-6.15M-4.77M
Net Cash FlowNCF
-13.06M0.75M-64.01M-31.97M-0.61M9.88M9.43M13.39M-28.73M-5.17M0.50M1.19M-4.55M0.82M-2.65M3.21M-5.18M